Developer of compounds to treat lung disease. The company is developing compounds for the treatment of human fibrotic disease, initially targeting idiopathic pulmonary fibrosis, a progressive life-threatening condition.
What you see here scratches the surface
We’ll help you find what you need
Ready to get started?
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.